...
首页> 外文期刊>Scientific reports. >Subclinical and overt hypothyroidism is associated with reduced glomerular filtration rate and proteinuria: a large cross-sectional population study
【24h】

Subclinical and overt hypothyroidism is associated with reduced glomerular filtration rate and proteinuria: a large cross-sectional population study

机译:亚临床和公开的甲状腺功能减退症与肾小球过滤速率和蛋白尿的降低相关:大横截面群体研究

获取原文
           

摘要

Subclinical hypothyroidism has been associated with dyslipidemia, hypertension, and increased risk of coronary artery disease. However, limited is known for its effect on renal function. Here we aimed to investigate whether subclinical hypothyroidism is associated with reduced estimated glomerular filtration rate (eGFR) and proteinuria in the general population. A cross-sectional cohort of 74,356 adults aged ≥20 year participating in voluntary health examinations without previous thyroid diseases were recruited in Taiwan. The mean eGFR of persons with euthyroidism, subclinical, and overt hypothyroidism are 87.99, 83.46, and 72.22?mL/min/1.73?m2, respectively (P-for- trend??0.001). The proportion of proteinuria in persons with euthyroidism, subclinical and overt hypothyroidism is 1.29%, 2.2%, and 2.97%, respectively (P-for-trend: 0.001). The odds ratio of CKD for subclinical, clinical, and all hypothyroidism is 2.04 (95% confidence interval (CI): 1.67-2.50) and 7.61 (95% CI: 4.92-11.77), and 2.41 (95% CI: 2.01–2.89), respectively as compared to euthyroidism. These odd ratios remained significant after further adjustments. The odds ratios for proteinuria is 2.04 (95% CI: 1.67–2.50), 7.61 (95% CI: 4.92–11.77), and 2.41 (95% CI: 2.01–2.89) for subclinical, clinical, and total hypothyroidism, respectively, although the odds ratios were attenuated after further adjustment. Our results suggest subclinical hypothyroidism is a novel risk factor of reduced renal function but not proteinuria.
机译:亚临床甲状腺功能减退症与血脂血症,高血压和冠状动脉疾病的风险增加有关。然而,有限地已知其对肾功能的影响。在这里,我们旨在调查亚临床甲状腺功能减退症是否与普通人口中估计的肾小球过滤速率(EGFR)和蛋白尿相关联。台湾招募了参加≥20年龄的74,356名成人≥20年的成年人,在台湾招募了未经以前的甲状腺疾病。患有Euth致毒性,亚临床和明显甲状腺功能减退症的人的平均EGFR分别为87.99,83.46和72.22?ml / min / 1.73?m2(p-for-trend?<0.001)。蛋白尿中蛋白尿中蛋白尿的比例分别为1.29%,2.2%和2.97%(p-for-trend:0.001)。 CKD对亚临床,临床和所有甲状腺功能亢进的差距为2.04(95%置信区间(CI):1.67-2.50)和7.61(95%CI:4.92-11.77)和2.41(95%CI:2.01-2.89 ),分别与Euth致毒性相比。在进一步调整后,这些奇数比率保持显着。蛋白尿的差距为2.04(95%CI:1.67-2.50),7.61(95%CI:4.92-11.77),以及亚临床,临床和总甲状腺功能减退症的2.41(95%CI:2.01-2.89),虽然在进一步调整后,赔率比率衰减。我们的研究结果表明亚临床甲状腺功能减退症是肾功能降低而不是蛋白尿的新危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号